AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 73 filers reported holding AADI BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,434,426 | -29.6% | 296,369 | -0.6% | 0.00% | – |
| Q2 2023 | $2,038,477 | +5.7% | 298,023 | +11.9% | 0.00% | – |
| Q1 2023 | $1,928,338 | -71.8% | 266,345 | -49.9% | 0.00% | – |
| Q4 2022 | $6,826,690 | +93.2% | 532,088 | +112.8% | 0.00% | – |
| Q3 2022 | $3,533,000 | -46.5% | 250,060 | -53.3% | 0.00% | – |
| Q2 2022 | $6,599,000 | -27.4% | 535,614 | +0.0% | 0.00% | – |
| Q1 2022 | $9,089,000 | +20.9% | 535,578 | +72.0% | 0.00% | – |
| Q4 2021 | $7,520,000 | – | 311,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $129,063 | 17.55% |
| Alerce Investment Management, L.P. | 1,630,830 | $7,893,217 | 13.49% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $8,951,106 | 6.00% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $2,547,432 | 0.85% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.71% |
| Knott David M Jr | 265,000 | $1,283 | 0.49% |
| Ghost Tree Capital, LLC | 250,000 | $1,210,000 | 0.40% |
| Avoro Capital Advisors LLC | 2,849,402 | $13,791,106 | 0.22% |
| Lion Point Capital, LP | 82,423 | $398,927 | 0.18% |
| Soleus Capital Management, L.P. | 333,227 | $1,612,819 | 0.15% |